(480) 923-0802
Join Our Panel
Consulting
Insights
Podcast
DVI
About
Contact Us
Posts Tagged ‘drug
All Categories
Our Take Newsletter
Downloadable Articles
By the Numbers
August 10, 2020
Our Take: Trump’s executive order, CMS’ proposed payment rules offer hope to rural areas
Read More
August 03, 2020
Our Take: Late-stage trials of COVID-19 vaccine candidates get underway as BARDA agrees to additional funding for vaccine development, production
Read More
July 27, 2020
Our Take: Trump renews efforts to lower drug prices ahead of election
Read More
January 20, 2020
Our Take: New developments ahead for drug development, from genomics to generics
Read More
December 09, 2019
Our Take: Partners rebrands; announces five-year strategic priorities
Read More
November 25, 2019
Our Take: Alternative payment models continue to gain traction, new survey shows
Read More
November 18, 2019
Our Take: U.S. government sues Gilead Sciences in dispute over PrEP patents
Read More
November 11, 2019
Our Take: Haven pilots insurance plans for employees in six states
Read More
November 04, 2019
Our Take: Walgreens ratchets up efforts to boost profitability, will close company-owned in-store clinics
Read More
October 28, 2019
Our Take: Biogen’s aducanumab gets a second life
Read More
September 09, 2019
Our Take: Judge rules against Johnson & Johnson in landmark opioid case
Read More
August 12, 2019
Our Take: FDA threatens legal action against Novartis over faulty data used in application for $2.1 million gene therapy
Read More
August 12, 2019
Episode 65: Our Take, August 12, 2019
Read More
August 05, 2019
Our Take: CMS gears up for fiscal year 2020
Read More
Posts navigation
Previous
1
…
13
14
15
Next
Sign up for Our Take
the weekly strategic brief for Health Care Executives
Please leave this field empty
Business Email
*
Check your inbox or spam folder to confirm your subscription.
share
Contact Darwin Research Group and we will get right back to you.
Please leave this field empty.
Consulting
Insights
Podcast
DVI
About
Contact Us